Abstract
1 The design of the classical three segment reproductive test for new drugs is described and the relative merits of the USA/EEC and the Japanese guidelines are discussed.
3 Changing ideas on the design of multi-generation studies are reviewed.
4 Recent developments in the fields of behavioural teratology, chemicals in breast milk and transplacental carcinogenesis are described.
Get full access to this article
View all access options for this article.
